Expanding Reach of Evidence-based Psychotherapy for Veterans With Co-occurring Anxiety and Substance Use Disorders.

Not Applicable

Completed

• Conditions: Anxiety Disorders; Substance Use Disorders
• Interventions: Behavioral: VA Coordinated Anxiety Learning and Management- Substance Use Version; Behavioral: Usual care

• Registration Number: NCT05372185
• Lead Sponsor: Baylor College of Medicine

Brief Summary

The current study seeks to better understand how to improve access to evidence-based psychotherapy (EBP) for rural Veterans with co-occurring anxiety and substance use disorders (SUD) using a web-based cognitive behavioral therapy tool (VA Coordinated Anxiety Learning and Management, Substance Use Version; VA CALM-S).

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-25
• Study First Submitted: 2022-05-09
• Study First Submitted QC: 2022-05-09
• Study First Posted: 2022-05-12
• Primary Completion: 2024-03-28
• Study Completion: 2024-03-30
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-24
• Last Update Posted: 2024-05-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

• current anxiety disorder diagnosis
• current SUD

Exclusion Criteria

• current substance withdrawal such that medically supervised detoxification is necessary (determined by evaluation of substance use history and report of current symptoms),
• acute suicidality
• current delusions/hallucinations.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
VA CALM-S	VA Coordinated Anxiety Learning and Management- Substance Use Version	Active psychotherapy using VA CALM-S, a weekly (9-12 sessions) cognitive behavioral therapy addressing co-occurring anxiety and substance use disorders, using disorder specific and transdiagnostic tools.
Usual Care	Usual care	Participants in usual care will engage with VA healthcare using standard procedures of their facility.

Primary Outcome Measures

Name	Time	Method
Generalized Anxiety Disorder-7	12 weeks	Self report measure of anxiety symptoms (score range 0-21), higher scores indicate greater anxiety (i.e., poorer outcome).

Secondary Outcome Measures

Name	Time	Method
Substance use frequency	12 weeks	Number of substance use days

Trial Locations

Locations (1)

Michael E DeBakey VAMC; 🇺🇸 Houston, Texas, United States